Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Evaluation of response assessment in chronic lymphocytic leukaemia using measurable residual disease by flow cytometry: Prospective observational study.

Karthik Jayalingappa, Bhawana Adhikari, Prisla Dalton, Bivant Shah, Kavya Ronanki, Paras Satadeve, Adamya Gupta, Reshma Benson, Arjun Kachhwaha, Shalini Singh, Manisha Naithani, Neha Singh, Prof. Uttam Kumar Nath

Blood (2025) 146 (Supplement 1): 7438.

https://doi.org/10.1182/blood-2025-7438

Published: 2025

Journal Articles

Predictive significance of early bone marrow MRD response assessment in Acute Myeloid Leukemia patients treated with venetoclax plus decitabine induction therapy: Real-world data from India

Arjun Kachhwaha, Mmcmedicine Benson, Paras Satadeve, Adamya Gupta, Bivant Shah, Prisla Dalton, Kavya Ronanki, Karthik Kumar, Sashi Singh, Jhasaketan Nayak, Nikhil Nagpal, Neha Singh, Harish Chandra, Prof. Uttam Kumar Nath

Blood (2025) 146 (Supplement 1): 7043.

https://doi.org/10.1182/blood-2025-7043

Published: 2025

Journal Articles

Comparison of consecutive versus alternate day schedules of high-dose cytarabine consolidation chemotherapy in Acute Myeloid Leukemia: Single-center randomized controlled trial from India

Kavya Ronanki, Bibhant Shah, Prisla Dalton, Adamya Gupta, Paras Satadeve, Reshma Benson, Arjun Kachhwaha, Nikhil Nagpal, Amit Sehrawat, Karthik Kumar, Karthik Jayalingappa, Anusha Mritunjayswamy, Mayank Kapoor, Prof. Uttam Kumar Nath

Blood (2025) 146 (Supplement 1): 1687.

https://doi.org/10.1182/blood-2025-1687

Published: 2025

Journal Articles

Real-world impact of high-risk cytogenetics and revised ISS (R2 ISS) on response and survival in multiple myeloma patients treated with various induction regimens: A single-center study from India.

Bibhant Shah, Kavya Ronanki, Prisla Dalton, Arjun Kachhwaha, Reshma Benson, Nikhil Nagpal, Paras Satadeve, Adamya Gupta, Karthik Jayalingappa, Prof. Uttam Kumar Nath

Blood (2025) 146 (Supplement 1): 8149.

https://doi.org/10.1182/blood-2025-8149

Published: 2025

Journal Articles

Dynamic changes in myeloid derived suppressor cells subsets in pediatric B cell acute lymphoblastic leukemia : Correlation with measurable residual disease status.

Prisla Dalton, Kavya Ronanki, Bivant Shah, Nikhil Nagpal, Mmcmedicine Benson, Arjun Kachhwaha, Adamya Gupta, Paras Satadeve, Neha Singh, Prof. Uttam Kumar Nath

Blood (2025) 146 (Supplement 1): 1598.

https://doi.org/10.1182/blood-2025-1598

Published: 2025

Journal Articles

Treatment Outcomes of Pediatric & AYA Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Using Upfront Generic Dasatinib & Augmented ALL IC-BFM 2009 Chemotherapy Protocol: A Single-Center Study from India

Adamya Gupta, Karthik Kumar, Sashi Singh, Paras Satadeve, Arjun Kachhwaha, Reshma Benson, Jhasaketan Nayak, Kavya Ronanki, Bibhant Shah, Prisla Dalton, Nikhil Nagpal, Sudhahar T, Vinod Kumar, Neha Singh, Uttam Kumar Nath

Blood (2024) 144 (Supplement 1): 5866.

https://doi.org/10.1182/blood-2024-210500

Published: 2024

Journal Articles

Real-World Data of Molecular Response Using Different Dosage of Upfront Generic Dasatinib in Chronic Phase Chronic Myeloid Leukemia: Single-Center Experience from India

Paras Satadeve, Sashi Singh, Adamya Gupta, Arjun Kachhwaha, Reshma Benson, Karthik Kumar, Jhasaketan Nayak, Kavya Ronanki, Bibhant Shah, Prisla Dalton, Nikhil Nagpal, Uttam Kumar Nath

Blood (2024) 144 (Supplement 1): 6614.

https://doi.org/10.1182/blood-2024-210857

Published: 2024

Journal Articles

Cytokine Behavior and Its Clinical Impact in Chronic Lymphocytic Leukemia: A Real-Time Study in India

Rupali Bains, Sudhahar T, Manisha Naithani, Anamika Bakliwal, Karthik Kumar, Paras Satadeve, Adamya Gupta, Kiran Meena, Anissa Atif Mirza, Harish Chandra, Yogesh Bahurupi, Uttam Kumar Nath, Karthik Jayalingappa, Prisla Dalton, Sashi Singh, Kavya Ronanki, Mukesh Mamgain

Blood (2024) 144 (Supplement 1): 6781.

https://doi.org/10.1182/blood-2024-209912

Published: 2024

Journal Articles

Treatment Outcomes in Acute Promyelocytic Leukemia Patients Using a Uniform ATRA + ATO Consolidation Therapy Regimen across All Risk Groups: A Single Centre Study from India

Reshma Benson, Arjun Kachhwaha, Paras Satadeve, Adamya Gupta, Karthik Kumar, Sashi Singh, Jhasaketan Nayak, Kavya Ronanki, Prisla Dalton, Bibhant Shah, Nikhil Nagpal, Uttam Kumar Nath

Blood (2024) 144 (Supplement 1): 1491.

https://doi.org/10.1182/blood-2024-210206

Published: 2024

Journal Articles

Real-World Experience with Generic Venetoclax Plus Hypomethylating Agent Induction Therapy in Newly Diagnosed Acute Myeloid Leukemia Patients in Resource-Limited Setting: A Single-Center Study from India

Arjun Kachhwaha, Reshma Benson, Paras Satadeve, Adamya Gupta, Bibhant Shah, Prisla Dalton, Kavya Ronanki, Karthik Kumar, Sashi Singh, Jhasaketan Nayak, Nikhil Nagpal, Shalini Singh, Neha Singh, Harish Chandra, Uttam Kumar Nath

Blood (2024) 144 (Supplement 1): 6047.

https://doi.org/10.1182/blood-2024-210666

Published: 2024

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Evaluation of response assessment in chronic lymphocytic leukaemia using measurable residual disease by flow cytometry: Prospective observational study.

Predictive significance of early bone marrow MRD response assessment in Acute Myeloid Leukemia patients treated with venetoclax plus decitabine induction therapy: Real-world data from India

Comparison of consecutive versus alternate day schedules of high-dose cytarabine consolidation chemotherapy in Acute Myeloid Leukemia: Single-center randomized controlled trial from India

Real-world impact of high-risk cytogenetics and revised ISS (R2 ISS) on response and survival in multiple myeloma patients treated with various induction regimens: A single-center study from India.

Dynamic changes in myeloid derived suppressor cells subsets in pediatric B cell acute lymphoblastic leukemia : Correlation with measurable residual disease status.

Treatment Outcomes of Pediatric & AYA Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Using Upfront Generic Dasatinib & Augmented ALL IC-BFM 2009 Chemotherapy Protocol: A Single-Center Study from India

Real-World Data of Molecular Response Using Different Dosage of Upfront Generic Dasatinib in Chronic Phase Chronic Myeloid Leukemia: Single-Center Experience from India

Cytokine Behavior and Its Clinical Impact in Chronic Lymphocytic Leukemia: A Real-Time Study in India

Treatment Outcomes in Acute Promyelocytic Leukemia Patients Using a Uniform ATRA + ATO Consolidation Therapy Regimen across All Risk Groups: A Single Centre Study from India

Real-World Experience with Generic Venetoclax Plus Hypomethylating Agent Induction Therapy in Newly Diagnosed Acute Myeloid Leukemia Patients in Resource-Limited Setting: A Single-Center Study from India

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only